ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,715.30
0.43%
S&P ASX All Technology
3,057.70
1.28%
Brent Oil
83.315
-0.19%
US Dollar vs AUD
1.51019
0.03%
Bitcoin
63,778.07
0.97%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Fusion Antibodies Plc (FAB)

  7. Fusion Antibodies Plc (FAB) News

FAB

Fusion Antibodies (FAB)

Fusion Antibodies Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FAB
DateTimeSourceHeadlineSymbolCompany
02/05/202416:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
01/05/202404:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:FABFusion Antibodies Plc
30/04/202416:00RNS Regulatory NewsFusion Antibodies PLC Year-end trading statementLSE:FABFusion Antibodies Plc
16/04/202416:00RNS Regulatory NewsFusion Antibodies PLC Change of auditorLSE:FABFusion Antibodies Plc
15/04/202422:29Alliance NewsAlliance NewsFusion Antibodies inks commercial contract for OptiPhage libraryLSE:FABFusion Antibodies Plc
15/04/202416:00RNS Regulatory NewsFusion Antibodies PLC Contract to develop a bespoke OptiPhage libraryLSE:FABFusion Antibodies Plc
03/04/202400:34RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
29/03/202404:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
12/03/202402:04RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
11/03/202420:10RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
09/03/202402:09RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
05/03/202421:40RNS Regulatory NewsFusion Antibodies PLC Result of General Meeting and Total Voting RightsLSE:FABFusion Antibodies Plc
01/03/202404:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
28/02/202401:18Alliance NewsAlliance NewsTRADING UPDATES: Sondrel wins USD23 million contractLSE:FABFusion Antibodies Plc
27/02/202418:00RNS Regulatory NewsFusion Antibodies PLC First purchase order under MSALSE:FABFusion Antibodies Plc
14/02/202422:27Alliance NewsAlliance NewsIN BRIEF: Fusion Antibodies raises GBP1.4 million via placingLSE:FABFusion Antibodies Plc
14/02/202418:15RNS Regulatory NewsFusion Antibodies PLC Grant of options and issue of shares to directorsLSE:FABFusion Antibodies Plc
14/02/202418:00RNS Regulatory NewsFusion Antibodies PLC Placing to raise £1,375,000LSE:FABFusion Antibodies Plc
06/02/202422:48Alliance NewsAlliance NewsFusion Antibodies strikes follow-on research and development projectLSE:FABFusion Antibodies Plc
06/02/202418:00RNS Regulatory NewsFusion Antibodies PLC Follow-on project award and R&D updateLSE:FABFusion Antibodies Plc
01/02/202423:00Alliance NewsAlliance NewsFusion Antibodies gets tax credit from UK HMRC for OptiMAL platformLSE:FABFusion Antibodies Plc
01/02/202418:00RNS Regulatory NewsFusion Antibodies PLC HMRC R&D tax creditLSE:FABFusion Antibodies Plc
04/12/202323:26UK RegulatoryFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
04/12/202321:22Alliance NewsAlliance NewsFusion Antibodies shares fall with revenue despite "positive" outlookLSE:FABFusion Antibodies Plc
04/12/202318:00UK RegulatoryFusion Antibodies PLC Half-year ReportLSE:FABFusion Antibodies Plc
29/11/202300:23Dow Jones NewsFusion Antibodies Shares Rise on US Cancer Institute CollaborationLSE:FABFusion Antibodies Plc
28/11/202323:09Alliance NewsAlliance NewsFusion Antibodies shares up on deal with US National Cancer InstituteLSE:FABFusion Antibodies Plc
28/11/202318:00UK RegulatoryFusion Antibodies PLC OptiMAL collaboration agreementLSE:FABFusion Antibodies Plc
09/11/202323:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Wincanton profit down; James Cropper ups payoutLSE:FABFusion Antibodies Plc
09/11/202318:00UK RegulatoryFusion Antibodies PLC Half year trading updateLSE:FABFusion Antibodies Plc
 Showing the most relevant articles for your search:LSE:FAB

Your Recent History

NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
FX
AUDCAD
AUD vs CAD
ASX
WPL
Woodside Petroleum
ASX
RIO
Rio Tinto
ASX
ANZ
Australia And New Zealan...
ASX
CBA
Commonwealth Bank Of Aus...
ASX
ORG
Origin Energy
NASDAQ
AMZN
Amazon.com
ASX
WES
Wesfarmers
ASX
WDC
Westfield
ASX
MQG
Macquarie
ASX
TLS
Telstra
FX
AUDUSD
AUD vs US Dollar
ASX
XJO
S&P ASX 200
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved